Bluebird Bio (NASDAQ: BLUE) hired former Sangamo Biosciences (NASDAQ: SGMO) chief scientific officer and research chief Phillip Gregory as its new CSO.
Sponsored · Whitepaper
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
From Our Partners · Special Report
Advice for funding and future transformational opportunities
